This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign In or Register
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

For Inflectra® (infliximab) Prescribing Information for Great Britain click here.
Adverse event reporting information can be found at the bottom of the page.



The primary endpoint was the the evaluation of safety in terms of rate of SAEs during the first year since the introduction of Inflectra/CT-P13* (infliximab) for the overall population.

Breakdown of SAEs experienced by the overall population.1

Adapted from Fliorino G. et al. 2017.

Explore more

Crohn’s disease safety

Learn about the safety profile of Inflectra in patients with Crohn’s disease

Learn more

Crohn’s disease dosing

Learn about the dosing and administration of Inflectra in patients with Crohn’s disease

Find out more

*CT-P13 is marketed under different brand names including Inflectra and REMSIMA®.
SAE=Serious adverse event
  1. Fiorino G, et al. Inflamm Bowel Dis 2017. 23:233–243.
PP-IFA-GBR-0503. September 2021

Quick Links

  • GONCZI L et al

  • Study 3.4

  • NOR-SWITCH safety

  • NOR-SWITCH efficacy

  • PROSIT-BIO safety

  • PROSIT-BIO efficacy

  • PROSIT-BIO study design

  • Switch studies

  • Paediatric studies

  • Induction & Maintenance

  • Inflammatory bowel disease

Learn about the evidence supporting the use of Inflectra in patients with rheumatoid arthritis. 

Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021



OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?